Assenagon Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $747M | Sell |
|
|||||
|
2025
Q2 | $804M | Buy |
|
|||||
|
2025
Q1 | $139M | Sell |
|
|||||
|
2024
Q4 | $353M | Sell |
|
|||||
|
2024
Q3 | $414M | Buy |
|
|||||
|
2024
Q2 | $226M | Buy |
|
|||||
|
2024
Q1 | $57.8M | Sell |
|
|||||
|
2023
Q4 | $332M | Buy |
|
|||||
|
2023
Q3 | $106M | Buy |
|
|||||
|
2023
Q2 | $64.3M | Buy |
|
|||||
|
2023
Q1 | $46M | Buy |
|
|||||
|
2022
Q4 | $40.5M | Sell |
|
|||||
|
2022
Q3 | $46.7M | Sell |
|
|||||
|
2022
Q2 | $97.4M | Sell |
|
|||||
|
2022
Q1 | $103M | Sell |
|
|||||
|
2021
Q4 | $110M | Sell |
|
|||||
|
2021
Q3 | $372M | Buy |
|
|||||
|
2021
Q2 | $114M | Buy |
|
|||||
|
2021
Q1 | $42.4M | Sell |
|
|||||
|
2020
Q4 | $136M | Buy |
|
|||||
|
2020
Q3 | $60.1M | Buy |
|
|||||
|
2020
Q2 | $44M | Buy |
|
|||||
|
2020
Q1 | $14.5M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $57.8M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.65M | Sell |
|
|||||
|
2018
Q3 | $70.6M | Buy |
|
|||||
|
2018
Q2 | $1.91M | Sell |
|
|||||
|
2018
Q1 | $18.1M | Buy |
|
|||||
|
2017
Q4 | $570K | Sell |
|
|||||
|
2017
Q3 | $58.8M | Buy |
|
|||||
|
2017
Q2 | $961K | Buy |
|